{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:53:04Z","timestamp":1788821584487,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.clml.2017.06.011","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T22:15:09Z","timestamp":1497910509000},"page":"676-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Elevated Cardiovascular Disease Risk in Patients With Chronic Myelogenous Leukemia Seen in Community-based Oncology Practices in the United States"],"prefix":"10.1016","volume":"17","author":[{"given":"Anna D.","family":"Coutinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinara","family":"Makenbaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Farrelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela B.","family":"Landsman-Blumberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lenihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2017.06.011_bib2","unstructured":"Howlander N, Noone AM, Krapcho M, et\u00a0al (eds). SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD. Available at: http:\/\/seer.cancer.gov\/csr\/1975_2013\/. Based on November 2015 SEER data submission, posted to the SEER web site, April 2016. Accessed: August 1,\u00a02016."},{"key":"10.1016\/j.clml.2017.06.011_bib3","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1002\/cncr.26679","article-title":"Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy","volume":"118","author":"Huang","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.06.011_bib4","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clml.2017.06.011_bib5","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ijcard.2013.03.133","article-title":"Cardioncology: state of the heart","volume":"168","author":"Todaro","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clml.2017.06.011_bib6","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJMra1100265","article-title":"Cardiovascular toxic effects of targeted cancer therapies","volume":"375","author":"Moslehi","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2017.06.011_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pcad.2010.06.002","article-title":"The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society","volume":"53","author":"Lenihan","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.clml.2017.06.011_bib8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2017.06.011_bib9","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","article-title":"Modifiable risk factors and major cardiac events among adult survivors of childhood cancer","volume":"31","author":"Armstrong","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.06.011_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ajh.22037","article-title":"Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML","volume":"86","author":"Aichberger","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2017.06.011_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.clml.2012.04.005","article-title":"Nilotinib-associated vascular events","volume":"12","author":"Quintas-Cardama","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2017.06.011_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2016.70.2944","article-title":"How does one decide which tyrosine kinase inhibitor to use for the initial treatment of chronic-phase chronic myeloid leukemia?","volume":"5","author":"Cortes","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.06.011_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00277-014-2231-9","article-title":"Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment","volume":"94","author":"Breccia","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2017.06.011_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12529-012-9242-5","volume":"19","author":"Perk","year":"2012","journal-title":"Int J Behav Med"},{"key":"10.1016\/j.clml.2017.06.011_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.clml.2015.09.008","article-title":"Use of real-world claim databases to assess prevalence of comorbid conditions relevant to the treatment of chronic myelogenous leukemia based on National Comprehensive Network Treatment Guidelines","volume":"15","author":"Jabbour","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2017.06.011_bib17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.clml.2017.06.011_bib18","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1200\/JCO.2015.65.5845","article-title":"Cardiovascular disease risk profiles in survivors of adolescent and young adult (AYA) Cancer: The Kaiser Permanente AYA Cancer Survivors Study","volume":"34","author":"Chao","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.06.011_bib19","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.jacc.2013.03.023","article-title":"Trends in predicted 10-year risk of coronary heart disease and cardiovascular disease among U.S. adults from 1999 to 2010","volume":"61","author":"Ford","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clml.2017.06.011_bib20","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","article-title":"Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.clml.2017.06.011_bib21","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.leukres.2011.12.020","article-title":"Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies","volume":"36","author":"Castillo","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2017.06.011_bib22","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1158\/1055-9965.EPI-09-0028","article-title":"Obesity, weight gain, and risk of chronic myeloid leukemia","volume":"18","author":"Strom","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clml.2017.06.011_bib23","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/aje\/kwv290","article-title":"Time-dependent risk of cancer after a diabetes diagnosis in a cohort of 2.3 million adults","volume":"183","author":"Dankner","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clml.2017.06.011_bib24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1158\/1055-9965.EPI-13-0093","article-title":"Lifestyle and dietary factors in relation to risk of chronic myeloid leukemia in the NIH-AARP Diet and Health Study","volume":"22","author":"Kabat","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017306791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017306791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T19:56:41Z","timestamp":1535745401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265017306791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2152265017306791"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2017.06.011","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated Cardiovascular Disease Risk in Patients With Chronic Myelogenous Leukemia Seen in Community-based Oncology Practices in the United States","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2017.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}